Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Neuropharmacology. 2012 Sep 1;63(8):1327–1334. doi: 10.1016/j.neuropharm.2012.08.020

Table 2.

Dopamine Uptake.

Sub-Region SHR/NCrl WKY/NCrl WKY/NHsd SD/NCrl
ADHD-C ADHD-PI Control Control
k−1 (sec−1) Dorsal Str 0.007 ± 0.001 0.009 ± 0.003 0.014 ± 0.003 0.014 ± 0.003
Intermediate Str 0.011 ± 0.003 0.009 ± 0.004 0.013 ± 0.003 0.009 ± 0.001
Ventral Str 0.010 ± 0.003 0.009 ± 0.004 0.011 ± 0.003 0.009 ± 0.001
NA Core 0.008 ± 0.002 0.008 ± 0.003 0.006 ± 0.001 0.008 ± 0.001
Trise (sec) Dorsal Str 7.95 ± 1.15 7.07 ± 0.94 7.85 ± 1.51 7.85 ± 1.51
Intermediate Str 5.71 ± 0.41 7.28 ± 0.75 8.24 ± 0.78 8.91 ± 3.38
Ventral Str 6.71 ± 1.38 7.64 ± 0.79 9.43 ± 0.83 10.3 ± 2.73
NA Core 9.25 ± 0.50 9.36 ± 0.85 12.9 ± 1.71 12.6 ± 3.5
Peak Amplitude (μM) Dorsal Str 0.89 ± 0.04 0.83 ± 0.04 0.75 ± 0.04 0.73 ± 0.04
Intermediate Str 0.74 ± 0.03 0.79 ± 0.04 0.77 ± 0.04 0.73 ± 0.02
Ventral Str 0.72 ± 0.04 0.74 ± 0.04 0.69 ± 0.03 0.82 ± 0.03
NA Core 0.73 ± 0.06 0.79 ± 0.02 0.66 ± 0.04 0.74 ± 0.03

k−1 values and the amount of time it took to reach the peak amplitude (Trise) did not vary between strains. Similar amplitudes of exogenous DA were applied to the Str and NAc and did not significantly differ (mean ± SEM).